In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Working Group Talk "Coronary physiology in the setting of chronic total occlusions"

Live Online Event of the ESC Working Group on Coronary Pathophysiology & Microcirculation

09/04/2024 16:00 09/04/2024 17:00 Europe/Paris Working Group Talk "Coronary physiology in the setting of chronic total occlusions"

Access event page

ESC Working Group on Coronary Pathophysiology & Microcirculation contact@escardio.org DD/MM/YYYY
Cardiovascular Disease in Special Populations
Online
event

Summary

This live talk chaired by Raffaele Bugiardini and Alfredo Ruggero Galassi covers coronary physiology in the setting of chronic total occlusions.

Omer Goktekin presents CTO-PCI and coronary physiology: a glimpse into the future, while Alfredo Ruggero Galassi presents CTO-PCI: acute and long-term results.

Chronic total occlusions (CTOs) are present in 15–30% of patients undergoing coronary angiography. Patients with a CTO have higher mortality, higher occurrence of ventricular arrhythmias, and higher degree of angina or dyspnea. Moreover, CTOs are often found in the context of multi-vessel disease where the coronary physiology assessment might play a role in the selection of those patients requiring myocardial revascularisation. 

However, the presence of a CTO makes the coronary physiological assessment of non-CTO lesions more complex, especially if these lesions involve the vessels supplying the CTO territory through collaterals. Finally, what is the role of collateral vessels, of coronary microvascular resistances, of collateral steal phenomena, of the lesion severity in the donor artery as well as what changes may occur in the CTO territory after CTO PCI is still debated. 

Aims

This talk aims to provide an update on frequent questions such as:

  • Why should a patient complain of new-onset symptoms caused by a CTO that has been present for months or even years? 
  • How does a stenosis in the donor artery affect CTO blood supply? 
  • What is the right timing for CTO PCI? 
  • What is the optimal revascularisation strategy in patients with multi-vessel disease and CTOs? 
  • What is the role of coronary physiological assessment before and after CTO PCI? 
  • What outcomes can be expected following CTO PCI?

Programme

Chairs 

Raffaele Bugiardini, IT

 

 

Alfredo Ruggero Galassi, IT

 

Presentation

CTO-PCI and coronary physiology: a glimpse into the future

Omer Goktekin.jpg

Omer Goktekin, TR

 

 

CTO-PCI: acute and long-term results

Alfredo Ruggero Galassi, IT

 

 

Resource